About us
We are a drug discovery hub located in the heart of London, where academic and industrial research meet. Our mission is to bridge the gap between these two communities and accelerate the discovery of new drugs. With a team of experts and state-of-the-art facilities, we are committed to making a difference in medical research.
The MRC LMS & Imperial Drug Discovery Hub is a cutting-edge facility that opened in June 2024. Our primary objective is to provide small molecule screening pipelines that are specifically designed for biological and medical research purposes. Our location at the Translation & Innovation Hub, White City Campus, London, places us at the heart of a thriving innovation ecosystem that fosters collaboration and knowledge sharing.
Our team of seasoned professionals works closely with academic and industrial partners to drive drug discovery forward. We offer a range of solutions, including target-based screening, phenotypic screening, and virtual screening. We actively curating extended small molecule libraries, and support researchers throughout every stage of the early drug discovery process. We are deeply committed to advancing the field of medicine and are excited to contribute to the ongoing progress of drug discovery. With our state-of-the-art facility and experienced team, we help researchers achieve their goals and aim to make a meaningful impact in the field of drug discovery.
